mHealth tool to boost hormone therapy adherence for Latina breast cancer patients
Official title: mHealth to Improve Medication Adherence Among Latina Breast Cancer Patients Experiencing Non-Medical Drivers of Health
Run by The University of Texas Health Science Center at San Antonio · NCT07706127 · Data updated 2026-11-12
A bilingual, culturally tailored smartphone app plus patient navigation is tested to help Latina women on hormone therapy take their medication as prescribed.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 159 (estimated) |
| Sponsor | The University of Texas Health Science Center at San Antonio Academic / other |
| Locations | 1 site (San Antonio, Texas) |
| Status | Recruiting |
| Started | September 26, 2025 |
| Main results expected | April 30, 2028 |
| Study ends | April 30, 2028 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07706127 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
English- or Spanish-speaking Latina women, 18+, on hormone therapy for hormone receptor-positive breast cancer, within 24 months of starting HT, with NMDoH barriers, and owning a smartphone with text and internet access.
✕Probably not a fit
Patients without non-medical barriers or without access to smartphone/text/internet may receive less or no added benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized approach examines whether the HT Helper app, when combined with patient navigation, improves adherence to hormone therapy among Latina breast cancer patients who face non-medical barriers. The study compares HT Helper plus navigation to navigation alone and to usual care over a four-year period. Participants must be English- or Spanish-speaking Latinas started on hormone therapy within the prior 24 months and must own a smartphone with text and internet access. The trial focuses on those experiencing NMDoH such as income, insurance, or literacy barriers. Outcomes include adherence measures and potential impacts on recurrence risk and mortality related to HT adherence.
Why it matters
Potential benefit: If successful, the intervention could improve HT adherence and potentially reduce breast cancer recurrence and mortality in Latina patients facing non-medical barriers.
How similar studies have gone: Previous work suggests digital health tools can support treatment adherence, though the effectiveness for NMDoH-targeted interventions in this population requires confirmation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: English- or Spanish-speaking Latina patients aged 18 and older who: a) are diagnosed with hormone receptor-positive breast cancer and prescribed HT; b) within 1 to 24 months of starting HT; c) are experiencing any NMDoH by the Avanzando Center NMDoH Screener; d) are able to read; e) own a smartphone and are able to send and receive text messages and access the Internet; and f) are able to provide informed consent to participate in the study. Exclusion Criteria: Not meeting the criteria above, or patients who: a) are not Latina and are younger than 18 years; b) are not receiving HT treatment; c) with more than 24 months of starting treatment; d) do not experience any NMDoH by the Avanzando Center NMDoH Screener; e) are unable to read; f) do not own a smartphone and are unable to send and receive text messages and access the Internet; g) are unable to respond to text messages and questions or unable to download the study app; h) are unable to provide informed consent due to a mental, emotional, or physical handicap that keeps them from understanding the consent information; i) are unable to see the app and study materials and videos (i.e., are blind, deaf); and j) currently participating in a psychosocial intervention trial or individual/group psychotherapy.
Where it's running
-
The University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States Recruiting
Study contacts
- Principal investigator: Patricia Chalela, DrPH, MPH — The University of Texas Health Science Center at San Antonio
- Study coordinator: Study Coordinator
- Email: HTHelper@uthscsa.edu
- Phone: 210-567-6523
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Impact of Food Help on Adherence to Cancer Treatment
This study tests whether providing food assistance helps adults with cancer who have food insecurity stick to their treatment plans.
-
Telenursing to detect and manage side effects from CDK4/6 inhibitors in breast cancer
This project tests whether scheduled phone or video contacts from trained nurses, added to usual care, help people with breast cancer taking CDK4/6 inhibitors notice and manage side effects earlier and stay on treatment.
-
Solution-focused therapy to improve psychosocial adjustment and medication adherence for people with schizophrenia
This program will try weekly one-on-one solution-focused therapy for six weeks to see if it helps adults with stable schizophrenia improve social adjustment and stick to their medications.
-
Evira: digital support added to obesity medication for teens
This study will try adding the Evira digital tool to obesity medication for 12–17-year-olds to see if it improves weight outcomes and sticking with treatment compared with medication alone.
-
Couple-focused mobile health intervention to improve CPAP use for sleep apnea
This study is testing if a mobile health program for couples can help people with sleep apnea use their CPAP machines more regularly and improve their quality of life.
-
Referral to alcohol treatment for patients with liver disease
This study tests whether sending newly diagnosed patients with alcohol-related liver disease to specialized treatment can help them stop drinking better than just regular care alone.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.